Form 8-K - Current report:
SEC Accession No. 0001437749-17-002584
Filing Date
2017-02-15
Accepted
2017-02-15 16:46:05
Documents
1
Period of Report
2017-02-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20170214c_8k.htm 8-K 38584
  Complete submission text file 0001437749-17-002584.txt   39826
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 17615218
SIC: 2834 Pharmaceutical Preparations